- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Keith Dunleavy, MD, Explains How Big Data Analytics Inform Better Healthcare Decisions
Keith Dunleavy, MD, president, CEO, and chairman of the board for Inovalon, Inc, says that healthcare is enormously complex, and that it's being driven across a broad range of audiences.
Keith Dunleavy, MD, president, CEO, and chairman of the board for Inovalon, Inc, says that healthcare is enormously complex, and that it’s being driven across a broad range of audiences. Because of this, data is particularly important for patient populations insured under Medicare or Medicaid managed care, Medicare Advantage, the health insurance exchange, and the accountable care organization marketplace.
“Data is driving what is the success or failure of healthcare in this new capitated managed care marketplace—and the importance of how it is to the actual consumer and their provider—is critical,” says Dr Dunleavy.
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder
July 23rd 2025Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.
Read More
